Showing 81-90 of 354 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Charting a Path for Continuous Insulin Monitoring | University of Cincinnati | Ryan White | Improving Lives | 01-April-2024 to 31-March-2027 | $708.147,00 |
| Treatment of type-1 diabetes with apolipoprotein A4 – efficacy and mechanisms | University of Cincinnati | Min Liu | Cures | 01-March-2023 to 28-February-2027 | $721.291,00 |
| Development of a Microfluidic Patch Pump for Next-Generation Wearable Artificial Pancreas Systems | University of California, Santa Barbara | Sumita Pennathur | Improving Lives | 01-May-2023 to 30-April-2026 | $1.063.204,78 |
| Reducing the Burden of Type 1 Diabetes Using Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances | University of California, San Diego | Schafer Boeder | Improving Lives | 01-July-2022 to 30-June-2027 | $749.956,58 |
| Assessment of impaired counterregulatory hormones and endothelial dysfunction using wearable sensors in people living with type 1 diabetes | University of California, San Diego | Robert Thomas | Improving Lives | 01-June-2026 to 31-May-2031 | $999.888,08 |
| IL-37 expressing Treg cells to improve T1D therapeutic strategy | University of California, San Diego | Mayumi Fujita | Cures | 01-September-2025 to 28-February-2027 | $161.904,81 |
| Microneedle Sensor for Simultaneous Continuous Monitoring of Ketone and Glucose | University of California, San Diego | Joseph Wang | Improving Lives | 01-October-2022 to 30-April-2027 | $867.998,91 |
| The Effects of Glucagon Antagonism on Insulin Resistance, Ketone Production, and Cardiovascular Risk in Individuals with Type 1 Diabetes | University of California, San Diego | Jeremy Pettus | Improving Lives | 01-June-2021 to 30-November-2026 | $1.233.752,52 |
| Acetazolamide and Tubuloglomerular Feedback in Persons with Type 1 Diabetes: A Clinical Trial | University of California, San Diego | Charles Ginsberg | Improving Lives | 01-November-2022 to 31-October-2026 | $1.356.726,45 |
| HSPC engineering of myeloid-restricted CAR circuit for pancreatic M2 Polarization in Type 1 Diabetes | University of California, San Diego | Anusha Sivakumar | Cures | 01-September-2026 to 31-August-2028 | $340.867,00 |